title: No increased risk of Taxol toxicity in older patients.
authors.forename: S M
authors.initials: SM
authors.lastname: Lichtman
authors.forename: W
authors.initials: W
authors.lastname: Zaheer
authors.forename: D
authors.initials: D
authors.lastname: Gal
authors.forename: J
authors.initials: J
authors.lastname: Lovecchio
authors.forename: L C
authors.initials: LC
authors.lastname: DeMarco
authors.forename: P
authors.initials: P
authors.lastname: Schulman
authors.forename: D R
authors.initials: DR
authors.lastname: Budman
authors.forename: R
authors.initials: R
authors.lastname: Taibbi
authors.forename: C
authors.initials: C
authors.lastname: Fenton
authors.forename: V
authors.initials: V
authors.lastname: Vinciguerra
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000187:drug effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects / Q000494:pharmacology*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel